Structure-Activity Relationship (Sar) And In Vivo Activity Of A Novel Series Of C5-Substituted Anilinoquinazolines With Highly Potent And Selective Inhibition Of C-Src Tyrosine Kinase Activity.
CLINICAL CANCER RESEARCH（2003）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined